X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INFLAMMATION

期刊標題檢索 INFLAMMATION 最新評論: Have you finally found the reference format? (2025-07-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INFLAMMATION]您好,您是該頁面的第 93192 位訪客。

期刊簡介
期刊名稱INFLAMMATION INFLAMMATION
LetPub Score
6.6
50 ratings
Rate

Reputation
7.8

Influence
5.5

Speed
7.2

期刊簡稱INFLAMMATION
ISSN0360-3997
E-ISSN1573-2576
h-index51
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.101.2701.039
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q139 / 231
Category: Medicine
Subcategory: Immunology
Q144 / 240

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Inflammation publishes the latest international advances in experimental and clinical research on the physiology, biochemistry, cell biology, and pharmacology of inflammation. Contributions include full-length scientific reports, short definitive articles, and papers from meetings and symposia proceedings. The journal's coverage includes acute and chronic inflammation; mediators of inflammation; mechanisms of tissue injury and cytotoxicity; pharmacology of inflammation; and clinical studies of inflammation and its modification.
官方網站https://www.springer.com/10753
在線稿件提交https://www.editorialmanager.com/ifla
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1975
每年文章數254每年文章數趨勢
黃金OA百分比19.08%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ263/204
IMMUNOLOGYSCIEQ142/183
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0360-3997%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【INFLAMMATION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 38.20
    Annual Review of ImmunologyH-index: 279

    CiteScore: 55.50
    ImmunityH-index: 355

    CiteScore: 40.80
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 36.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 21.20
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 22.10
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 16.80
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 15.20
    Mucosal ImmunologyH-index: 82

    CiteScore: 16.50
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology458362
    JOURNAL OF IMMUNOLOGY159137
    Immunity110784
    Cellular & Molecular Immunology110398
    Vaccine107156
    JOURNAL OF EXPERIMENTAL MEDICINE103873
    MOLECULAR IMMUNOLOGY101887
    MICROBIAL PATHOGENESIS100603
    IMMUNOLOGY93699
    MEDIATORS OF INFLAMMATION92850
  •  

    INFLAMMATION INFLAMMATION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/11)
  [INFLAMMATION] 的評論撰寫評論
作者: 小虾1004


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-30 20:37:08 評論於
Have you finally found the reference format?
(0) 讚! | 小虾1004

作者: xyzxh


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-26 08:16:17 評論於
$4790? Hmm...
(0) 讚! | xyzxh

作者: xyzxh


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-26 08:13:32 評論於
May I ask how much is the APC in USD now?
(0) 讚! | xyzxh

作者: 北方大虾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-05-01 10:50:06 評論於
Do we need the original WB images for the first submission of the manuscript?
(0) 讚! | 北方大虾

作者: 又是一年投稿日


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-04-22 16:04:04 評論於
The editing speed is very fast! The current feeling is that as long as it is a working day, they will not let the manuscript stay in hand overnight. The main time is stuck with the reviewers, but a reply can be received within a month.

Cons: Really expensive!!! OA in 2025, very very expensive!

Recommendation for students who do not have high requirements for the journal, hope it is helpful to everyone!
(0) 讚! | 又是一年投稿日

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-30 14:47:40 評論於
I have been using it for about a month, how about yours?
(0) 讚! | Adelaide Lawson

作者: 墟散孤晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 21:02:00 評論於
Submission success rate: 50.0 Experience sharing: This journal mainly requires original articles, and review articles are easily considered as garbage and will not be accepted. In addition, the impact factor found for 2024 is 4.5, compared to 5.1 last year.
(0) 讚! | 墟散孤晴

作者: Channing Timothy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-12 18:09:45 評論於
Same question, same question.
(0) 讚! | Channing Timothy

作者: Lee


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-21 20:36:24 評論於
May I ask if WB requires three replicates and full membrane?
(0) 讚! | Lee

作者: 中原淑芬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-05 10:58:45 評論於
Have you submitted it? How is the situation with this journal?
(0) 讚! | 中原淑芬

作者: 平原翠安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-08 08:01:20 評論於
How did it end in the end?
(0) 讚! | 平原翠安

作者: 关九于


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-08 02:46:39 評論於
Is it an OA you selected? How much is it in RMB approximately? Thank you
(0) 讚! | 关九于

作者: 水桥运来


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-05 14:45:54 評論於
Do you need all three stripes?
(0) 讚! | 水桥运来

作者: 关九于


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-02 23:37:59 評論於
Submitted at the end of January, received today, the review speed is very fast, and the editors are very efficient. They both sent it for review on the same day they received the manuscript
(0) 讚! | 关九于

作者: Darcy Christie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-19 23:23:46 評論於
Does this magazine accept submissions for reviews?
(0) 讚! | Darcy Christie

作者: 北风玄黓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-03 12:38:09 評論於
Hello, may I ask if any more reviewers have been added for the follow-up?
(0) 讚! | 北风玄黓

作者: 关九于


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-30 03:54:03 評論於
Very fast, submitted for review in one day. 
Good news will be commented again. 
Accumulate good deeds
(1) 讚! | 关九于

作者: 璧射力学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-19 21:28:49 評論於
Did you receive it? How long have you been using it?
(0) 讚! | 璧射力学

作者: 平原一然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 08:40:52 評論於
The article was rejected by the editor, who said that the grammar and writing need improvement. They then introduced some editing services. Should I revise it and resubmit?
(0) 讚! | 平原一然

作者: 鹰爪竹筱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-20 22:41:02 評論於
Do we need to repeat the raw data three times?
(0) 讚! | 鹰爪竹筱

作者: Chloe Bach


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-13 11:40:26 評論於
I would like to ask everyone where to find the reference format. I couldn't find it on the Endnote official website. Thank you, thank you. Help the child
(0) 讚! | Chloe Bach

作者: Chloe Bach


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-13 11:26:44 評論於
Hello, are you mainly working on the pathway? Do you use WB and PCR for validation? Or do you screen first with genomics?
(0) 讚! | Chloe Bach

作者: Norton Evan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 23:13:22 評論於
Could you please tell me who your reviewers are?
(0) 讚! | Norton Evan

作者: Norton Evan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 19:35:51 評論於
He won't answer until the reviewer finishes reading
(0) 讚! | Norton Evan

作者: Norton Evan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-10 09:09:32 評論於
Review speed: 2.0 | Submission hit rate: 95.0 Emphasis on research areas: asthma Experiences to share: Will there be additional reviewers for minor revisions in the second round of review, with one reviewer assigned for the first round?
(0) 讚! | Norton Evan

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/11)

開始撰寫 [INFLAMMATION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*